XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)Giovanni Luca Gravina, Claudio Festuccia, Andrea Mancini et al.|Journal of Hematology & Oncology|2014Cited by 72